Jin X - Search Results

1

CD90 affects the biological behavior and energy metabolism level of gastric cancer cells by targeting the PI3K/AKT/HIF-1α signaling pathway.

Gao L, Li J, He J, Liang L, He Z, Yue C, Jin X, Luo G, Zhou Y. Gao L, et al. Among authors: jin x. Oncol Lett. 2021 Mar;21(3):191. doi: 10.3892/ol.2021.12451. Epub 2021 Jan 7. Oncol Lett. 2021. PMID: 33574930 Free PMC article.

2

CD38 is involved in cell energy metabolism via activating the PI3K/AKT/mTOR signaling pathway in cervical cancer cells.

Liao S, Liang L, Yue C, He J, He Z, Jin X, Luo G, Zhou Y. Liao S, et al. Among authors: jin x. Int J Oncol. 2020 Jul;57(1):338-354. doi: 10.3892/ijo.2020.5040. Epub 2020 Apr 8. Int J Oncol. 2020. PMID: 32319590

3

Fra-1 Inhibits Cell Growth and the Warburg Effect in Cervical Cancer Cells via STAT1 Regulation of the p53 Signaling Pathway.

Zhang M, Liang L, He J, He Z, Yue C, Jin X, Gao M, Xiao S, Zhou Y. Zhang M, et al. Among authors: jin x. Front Cell Dev Biol. 2020 Sep 30;8:579629. doi: 10.3389/fcell.2020.579629. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33102485 Free PMC article.

4

CD38: A Significant Regulator of Macrophage Function.

Li W, Li Y, Jin X, Liao Q, Chen Z, Peng H, Zhou Y. Li W, et al. Among authors: jin x. Front Oncol. 2022 Feb 17;12:775649. doi: 10.3389/fonc.2022.775649. eCollection 2022. Front Oncol. 2022. PMID: 35251964 Free PMC article. Review.

5

'Reverse Warburg effect' of cancer‑associated fibroblasts (Review).

Liang L, Li W, Li X, Jin X, Liao Q, Li Y, Zhou Y. Liang L, et al. Among authors: jin x. Int J Oncol. 2022 Jun;60(6):67. doi: 10.3892/ijo.2022.5357. Epub 2022 Apr 15. Int J Oncol. 2022. PMID: 35425996 Review.

6

Effect of CD38 on B-cell function and its role in the diagnosis and treatment of B-cell-related diseases.

Zeng F, Zhang J, Jin X, Liao Q, Chen Z, Luo G, Zhou Y. Zeng F, et al. Among authors: jin x. J Cell Physiol. 2022 Jul;237(7):2796-2807. doi: 10.1002/jcp.30760. Epub 2022 Apr 29. J Cell Physiol. 2022. PMID: 35486480 Review.

7

Genetic variation of YWHAE gene-"Switch" of disease control.

Jin X, Dai M, Zhou Y. Jin X, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jan 28;47(1):101-108. doi: 10.11817/j.issn.1672-7347.2022.210394. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35545369 Free PMC article. Chinese, English.

8

FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy.

Zeng F, He J, Jin X, Liao Q, Chen Z, Peng H, Zhou Y. Zeng F, et al. Among authors: jin x. Biomed Pharmacother. 2022 Jun;150:113037. doi: 10.1016/j.biopha.2022.113037. Epub 2022 Apr 30. Biomed Pharmacother. 2022. PMID: 35658206 Free article. Review.

9

A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer.

Peng W, Lin C, Jing S, Su G, Jin X, Di G, Shao Z. Peng W, et al. Among authors: jin x. Front Oncol. 2021 Sep 16;11:746763. doi: 10.3389/fonc.2021.746763. eCollection 2021. Front Oncol. 2021. PMID: 34604089 Free PMC article.

10

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.

Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Among authors: jin x. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,635 results

Search Page

Filters